Delivery Order SPE2DB24D2216-SPE2DB25FGPVQ
- Not listed
- The Defense Logistics Agency awarded a $1,036.20 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mydayis ER 50 mg capsules (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mydayis is an extended-release formulation used in the treatment of attention-deficit/hyperactivity disorder and represents...
- The Defense Logistics Agency awarded a delivery order valued at $4,773.28 to AmerisourceBergen Drug Corp for 100 capsules of MYDAYIS ER 50 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYDAYIS ER 25 mg capsules (100-count units) valued at $1,061.94 under a firm fixed price contract. This non-set-aside delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYDAYIS is a prescription amphetamine-based medication used to treat...
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for 100 capsules of MYDAYIS ER 25 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply performed at the contractor's Conshohocken, Pennsylvania location. MYDAYIS is an extended-release amphetamine-based medication used in the treatment of attention deficit hyperactivity disorder (ADHD). This delivery order...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,551.53 to AmerisourceBergen Drug Corp for Mydayis capsules 12.5mg on September 19, 2025, with completion expected by September 22, 2025. This firm fixed-price delivery order represents a pediatric attention-deficit/hyperactivity disorder medication procurement supporting federal medical operations. The award utilized no set-aside designation, indicating competitive award of this pharmaceutical delivery through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 11, 2025, for the supply of Mydayis capsules 50mg to support federal medical procurement needs. This firm fixed price delivery order, valued at $6,302.72 with an ultimate completion date of September 12, 2025, was competitively awarded without set-aside designation to the Defense Logistics Agency's Medical Supply Chain division. The place of...
- The Defense Logistics Agency Troop Support Medical awarded a $543.66 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 capsules of MYDAYIS ER 25 MG CAPSULE. The place of performance will be Conshohocken, Pennsylvania from September 11-12, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle but details of the underlying contract were not provided. Amerisourcebergen will fulfill the requested...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $513.18 to Amerisourcebergen Drug Corp for the supply of 100 capsules of MYDAYIS ER 12.5 MG. Amerisourcebergen Drug Corp will deliver the medication to a location in Conshohocken, Pennsylvania by August 4, 2023 under the terms of the order. The prime contractor, Amerisourcebergen Drug Corp, is a division of Amerisourcebergen Corporation. The Defense Logistics Agency is the funding agency for this delivery of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical supplier. The $1,087.34 contract is for the supply of MYDAYIS ER 25 MG CAPSULE 100S to be delivered by March 6, 2024. Amerisourcebergen Drug Corp's Corporate Office in Conshohocken, Pennsylvania will be the place of performance. This delivery order is part of a larger...
- The Defense Logistics Agency Troop Support Medical awarded a $553.51 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 100 capsules of MYDAYIS ER 50 MG CAPSULE. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from September 15, 2023 through September 18, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency Troop Support Medical supports...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPVQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Mydayis ER 50 mg capsules (100-count units) with a ceiling value of $1,445.74. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competitive procurement. The order is scheduled for completion by September 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications and medical supplies across multiple therapeutic domains to support military and federal healthcare programs worldwide. The company's substantial presence in federal pharmaceutical distribution, combined with its competitive contract awards across various product categories, positions it as a critical vendor for the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/19/25 |